No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ACAD250117C29000
- 0.00
- 0.000.00%
15min DelayClose Jan 7 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest29.00Strike Price0.00Turnover0.00%IV66.76%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.70Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
ACADIA Pharmaceuticals Analyst Ratings
Guggenheim Downgrades ACADIA Pharmaceuticals(ACAD.US) to Hold Rating, Announces Target Price $20
Express News | ACADIA Pharmaceuticals Inc : Guggenheim Cuts Target Price to $20 From $23
Express News | ACADIA Pharmaceuticals Inc : Guggenheim Cuts to Neutral From Buy
Top Midday Gainers
ACADIA Pharmaceuticals Up Over 11%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk